Pharmacokinetics of a single dose of rimantadine in young adults and children.
Single doses of rimantadine were given to children and young adults to evaluate the safety and pharmacokinetics of this antiviral compound. The half-life of rimantadine in young adults was 27.7 +/- 4.9 h for tablets and 27.8 +/- 8.0 h for syrup preparations. A total of 10 children, 5 to 8 years old,...
Guardado en:
| Publicado en: | Antimicrob Agents Chemother |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1987
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174886/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3662473/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.7.1140 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|